On June 28th, Abbott commissioned a third-party auditor to conduct a GMP compliance audit on Dahua Pharmaceutical. As one of the key clients of the company, the purpose of this Abbott audit is to check whether the company's quality management system meets Abbott's requirements for qualified suppliers. This is also another challenge that Dahua Pharmaceutical is facing in the current epidemic situation.

After a brief understanding of the company's product characteristics, production processes, and quality management, the auditor teacher began a serious and meticulous review work. The inspection content is mainly divided into two parts: one is the viewing of document information, involving GMP documents, production inspection records, verification materials, etc; The second is on-site inspection. The audit teacher conducted a detailed inspection of the clean workshop production site, quality control department inspection site, public facilities, and warehouse storage site. During the audit process, employees from various departments of the company actively cooperated, timely provided the necessary documents and information for the audit, and provided detailed answers to the questions raised by the audit teacher.

After two days of inspection, the audit teacher recognized and positively evaluated the overall level and operation of Dahua Pharmaceutical's quality management system. They believed that Dahua Pharmaceutical's temporary inspection process responded quickly, provided complete information, had a problem-solving process, and the system operated effectively. The final audit result was satisfactory. In response to the identified defects and the rationalization suggestions put forward by the audit teacher, Dahua Pharmaceutical will formulate effective measures, conscientiously implement them, and effectively ensure the continuous and effective operation of the system.

The two-day audit work has ended, and Dahua Pharmaceutical has not stopped moving forward. As a pharmaceutical company, Dahua Pharmaceutical deeply understands that product quality is related to the life and health of consumers and is the first lifeline of enterprise survival. In the future work, Dahua Pharmaceutical will continue to strictly abide by the quality control, continuously improve the quality management system, enhance management level, and safeguard the high-quality and healthy development of the enterprise!